Which has grown faster, CRSP or SHC?

Over the past five years, CRSP grew revenue faster — CRSP at a 37.32% CAGR versus SHC at 6.66%.

Is CRSP or SHC more profitable?

SHC runs the higher net margin — CRSP at -3368.72% versus SHC at 13.44%.

How have CRSP and SHC total returns compared?

Over the past 5 years, CRSP delivered -10.97% and SHC delivered -6.39% annualized total return. Past performance doesn't predict future results.

CRISPR Therapeutics AG (CRSP) vs Sotera Health Company (SHC)

A side-by-side comparison of CRISPR Therapeutics AG and Sotera Health Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CRSP

CRISPR Therapeutics AG

$5.27B

$54.59HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

SHC

Sotera Health Company

$5.24B

$18.39HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

Total return — CRSP vs SHC

growth of $100 · dividends reinvested · last 6y

CRSP -47.5% (-10.2%/yr)SHC -26.1% (-4.9%/yr)SHC compounded faster over this window

CRSP SHC

CRSP vs SHC: by the numbers

•CRSP is the larger company ($5.27B vs $5.24B market cap).
•SHC is profitable (13.44% net margin) while CRSP runs a net loss (-3368.72%).
•CRSP grew revenue faster over the past five years (37.32% vs 6.66% CAGR).

Metrics side by side

Valuation

Metric	CRSP	SHC
P/E ratio	N/A	32.12
Forward P/E	N/A	18.68
P/S ratio	393.16	4.31
P/B ratio	3.01	7.88
EV / EBITDA	N/A	12.49
FCF yield	N/A	2.15%

Profitability

Metric	CRSP	SHC
Gross margin	-6537.01%	54.72%
Operating margin	-16191.40%	36.24%
Net margin	-3368.72%	13.44%
ROE	-25.83%	24.56%
ROIC	-21.12%	8.80%

Growth (annualized)

Metric	CRSP	SHC
Revenue CAGR (5Y)	37.32%	6.66%
FCF CAGR (5Y)	N/A	17.34%
Total return CAGR (5Y)	-10.97%	-6.39%

Frequently asked

Which has grown faster, CRSP or SHC?: Over the past five years, CRSP grew revenue faster — CRSP at a 37.32% CAGR versus SHC at 6.66%.
Is CRSP or SHC more profitable?: SHC runs the higher net margin — CRSP at -3368.72% versus SHC at 13.44%.
How have CRSP and SHC total returns compared?: Over the past 5 years, CRSP delivered -10.97% and SHC delivered -6.39% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CRSP analysis Full SHC analysis Interactive comparison tool

Dig into the metrics

Sotera Health P/E ratio CRISPR Therapeutics AG ROE Sotera Health ROE CRISPR Therapeutics AG operating margin Sotera Health operating margin CRISPR Therapeutics AG revenue growth Sotera Health revenue growth CRISPR Therapeutics AG free cash flow Sotera Health free cash flow

CRISPR Therapeutics AG & Sotera Health appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.